Longwood Capital Partners LLC Buys KalVista Pharmaceuticals Inc, Endocyte Inc, Amarin Corp PLC, Sells Immunomedics Inc, Iovance Biotherapeutics Inc, Ascendis Pharma A/S

• New Purchases: KALV, ECYT, AMRN,
• Added Positions: XENE, CHRS,
• Reduced Positions: IMMU, IOVA, ASND, VCYT, ASMB, VRAY, KDMN, ARWR, BHVN, ALIM,
• Sold Out: NTEC, CBIO, SRPT, VKTX, OBSV, ZGNX, CUTR, APLS, MEIP, FENC,

For the details of Longwood Capital Partners LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Longwood+Capital+Partners+LLC

1. Immunomedics Inc (IMMU) - 2,055,500 shares, 15.72% of the total portfolio. Shares reduced by 56.73%
2. Assembly Biosciences Inc (ASMB) - 930,000 shares, 12.68% of the total portfolio. Shares reduced by 19.97%
3. Iovance Biotherapeutics Inc (IOVA) - 2,222,701 shares, 9.18% of the total portfolio. Shares reduced by 44.78%
4. Kadmon Holdings Inc (KDMN) - 7,395,000 shares, 9.07% of the total portfolio. Shares reduced by 18.38%
5. Chembio Diagnostics Inc (CEMI) - 2,030,533 shares, 7.83% of the total portfolio.

Longwood Capital Partners LLC initiated holding in KalVista Pharmaceuticals Inc. The purchase prices were between $8 and $22.11, with an estimated average price of $13.49. The stock is now traded at around $18.40. The impact to a portfolio due to this purchase was 1.05%. The holding were 128,844 shares as of 2018-09-30.

Longwood Capital Partners LLC initiated holding in Endocyte Inc. The purchase prices were between $13.6 and $19.95, with an estimated average price of $17.15. The stock is now traded at around $23.85. The impact to a portfolio due to this purchase was 0.6%. The holding were 92,000 shares as of 2018-09-30.

Longwood Capital Partners LLC initiated holding in Amarin Corp PLC. The purchase prices were between $2.45 and $16.27, with an estimated average price of $3.75. The stock is now traded at around $22.68. The impact to a portfolio due to this purchase was 0.42%. The holding were 71,000 shares as of 2018-09-30.

Longwood Capital Partners LLC sold out a holding in Intec Pharma Ltd. The sale prices were between $3.65 and $5.65, with an estimated average price of $4.24.

Longwood Capital Partners LLC sold out a holding in Catalyst Biosciences Inc. The sale prices were between $9.35 and $12.44, with an estimated average price of $10.56.

Longwood Capital Partners LLC sold out a holding in Sarepta Therapeutics Inc. The sale prices were between $115.31 and $161.51, with an estimated average price of $136.71.

Longwood Capital Partners LLC sold out a holding in Viking Therapeutics Inc. The sale prices were between $9.7 and $19.65, with an estimated average price of $11.89.

Longwood Capital Partners LLC sold out a holding in ObsEva SA. The sale prices were between $10.92 and $18.18, with an estimated average price of $14.68.

Longwood Capital Partners LLC sold out a holding in Zogenix Inc. The sale prices were between $43.25 and $61.35, with an estimated average price of $50.75.